At Rush University Medical Center, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.
Medication Treatment Study for snOH in Subjects with Primary Autonomic Failure
The SEQUOIA Study is a research study looking at a study drug for people with conditions such as Parkinson’s disease (PD) or multiple system atrophy (MSA) who have a drop in blood pressure upon standing. We want to learn how safe the study drug is and whether it can reduce these symptoms. Participation will last about 9 weeks, with 7 study visits.
In order to participate you must meet the following criteria:
- Have been diagnosed with Parkinson’s disease (PD) or multiple system atrophy (MSA),
- Have symptoms such as dizziness, light-headedness, feeling faint, or feeling like you might black out upon standing.
- Are 30 years of age or older.
- Meet additional eligibility criteria.
This is a partial list of inclusion and exclusion criteria.